Resources>Upcoming Events>Festival of Biologics Europe 2026

Festival of Biologics Europe 2026

Biointron 2026-01-10

fobeurope.png

Biointron is delighted to announce our participation in the Festival of Biologics Europe 2026, taking place October 13 – 15, 2026, at Basel, Switzerland. The Festival of Biologics Europe is one of Europe’s most comprehensive gatherings for professionals across the biologic therapeutics ecosystem, spanning discovery, development, clinical trials, manufacturing, and commercialization.  

Organized by Terrapinn, this event brings together leading scientists, biotech and pharma innovators, investors, and solution providers to explore advances in antibody therapeutics, immunotherapies, cell and gene therapies, biosimilars, and related biologics disciplines. With hundreds of expert presentations, panel discussions, workshops, and networking opportunities, Festival of Biologics is designed to foster collaboration and accelerate progress in large-molecule drug development.  

Biointron is eager to connect with peers from across the industry, share insights on cutting-edge biologics platforms, and engage in strategic conversations that help drive innovation forward. 

We look forward to meeting colleagues and partners in San Diego this March at Festival of Biologics USA 2026! 

For more details about the event, please visit the Festival of Biologics Europe 2026 website [https://www.terrapinn.com/conference/festival-of-biologics/index.stm

Time: October 13 – 15, 2026 

Location: Messe Basel | Basel, Switzerland 

Booth: TBD 


Subscribe to our Upcoming Events
Explore More Events
BIO Korea 2026

Time: April 28 – 30, 2026
Location: Seoul, South Korea
Booth: #B31

Immunology 2026

Time: April 15 - 19, 2026
Location: Boston, MA
Booth: #1228

Antibody Therapeutics Conference Taiwan 2026

Time: May 26 - 27, 2026
Location: Taipei, Taiwan

CHABS 2026 Annual Conference

Time: May 9 - 10, 2026
Location: Boston, MA

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.